• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
  • View Item
  •   LillOA Home
  • Liste des unités
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Specific immune landscapes and immune ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article original
DOI :
10.1080/2162402X.2020.1792036
PMID :
32923153
Permalink :
http://hdl.handle.net/20.500.12210/75172
Title :
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
Author(s) :
Dufresne, A. [Auteur]
Lesluyes, T. [Auteur]
Menetrier-Caux, C. [Auteur]
Brahmi, M. [Auteur]
Darbo, E. [Auteur]
Toulmonde, Maud [Auteur]
Italiano, A. [Auteur]
Mir, O. [Auteur]
Le Cesne, Axel [Auteur]
Le Guellec, S. [Auteur]
Valentin, T. [Auteur]
Chevreau, C. [Auteur]
Bonvalot, S. [Auteur]
Robin, Y. M. [Auteur]
Coindre, J.-M. [Auteur]
Caux, C. [Auteur]
Blay, J. Y. [Auteur]
Chibon, F. [Auteur]
Journal title :
Oncoimmunology
Abbreviated title :
OncoImmunology
Volume number :
9
Publication date :
2020-01-01
ISSN :
2162-402X
Keyword(s) :
predictive factor
Soft tissue sarcoma
immunologic landscape
gene expression
histological diagnosis
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Soft tissue sarcomas are a group of rare and aggressive connective tissue neoplasms for which curative therapeutic opportunities are limited in advanced phase. Clinical trials assessing immunotherapy in these tumors have ...
Show more >
Soft tissue sarcomas are a group of rare and aggressive connective tissue neoplasms for which curative therapeutic opportunities are limited in advanced phase. Clinical trials assessing immunotherapy in these tumors have so far reported limited efficacy. The objective of this study is to provide a description of the immunologic landscape of sarcomas to guide the next clinical trials of immunotherapy in these diseases. The gene expression profile of 93 immune checkpoint (ICP) and membrane markers (MM) of immune cells was analyzed in a series of 253 soft tissue sarcoma (synovial sarcoma, myxoid liposarcoma, sarcoma with complex genomic and GIST) using Agilent Whole Human Genome Microarrays. The unsupervised hierarchical clustering of gene expression level was found able to properly group patients according to the histological subgroup of sarcoma, indicating that each sarcoma subgroup is associated with a specific immune signature defined by its gene expression pattern. Using the prognostic impact of CIBERSORT signature on metastatic-free survival in each subgroup, specific target could be proposed for each of the four groups: Treg through ICOS and GITR in GIST, M0 macrophages in all four sarcoma subtypes, OX40 in SS, CD40 in GIST and SS. The immune landscape of sarcoma was found to be as heterogeneous as the histotypes and molecular subtypes, but strongly correlated to the histotype. Histotype adapted immunotherapeutic approaches in each sarcoma subtypes must be considered in view of these results, consistently with the already reported specific response of histotypes of ICPs.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
INSERM
Université de Lille
Collections :
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Submission date :
2022-06-15T13:59:39Z
Files
Thumbnail
  • 2020-01-01-Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma.pdf
  • Version éditeur
  • Open access
  • Access the document
Université de Lille

Mentions légales
Université de Lille © 2017